Taislim Breaking News

I received this email this morning and have copied exactly as received:

"FreeLife International Presents Results of Successful Clinical Studies at Annual Obesity Society Meeting

PHOENIX, AZ – October 28, 2009 – FreeLife International recently presented the significant results of several human clinical studies on TAIslim™, its proprietary triple-patent pending liquid weight loss supplement, at the 27th Annual Scientific Meeting of The Obesity Society. This important conference, held in Washington, DC, brought together the world’s leading players in the field of obesity - from basic and clinical researchers and clinicians to educators, advocates, policy shapers and practitioners.

At the conference, FreeLife’s Chief Scientific Officer Dr. Haru Amagase presented research on the impact of TAIslim on weight management. He discussed TAIslim’s unique mode of action and the significant reductions in body weight, body mass index (BMI), waist and hip circumferences observed in several controlled human clinical studies. TAIslim was also found to cause significant improvements over placebo in blood pressure, fasting glucose levels and total body fat content. The formula was developed after weight loss benefits were noted in clinical studies on two other FreeLife supplements – GoChi® and Chi3 Energy, both of which are based on the Asian goji berry (Lycium barbarum).

FreeLife’s findings on TAIslim will be published in the respected journal Obesity. “These results are very interesting and promising,” remarked Dr. Marie-Pierre St-Onge, noted obesity research expert and Assistant Professor at St. Luke's/Roosevelt Hospital and New York Obesity Research Center at Columbia University. She added, “The rise in energy expenditure (i.e., fat burning) with these goji-based products is interesting and suggests a mechanism by which they can assist in weight management.”

“Lycium barbarum is a very interesting herb,” stated Dr. Norman R. Farnsworth, world-renowned Professor of Pharmacognosy (study of plant-based medicines) at the University of Illinois at Chicago. “Clinical studies have shown multiple health benefits for humans, especially for general well-being, for immune-modulation and for its antioxidant effects. The medicinal properties of Lycium barbarum in traditional Asian medicine correlate well with recent scientific studies. It appears that the active compounds in Lycium barbarum are polysaccharides (LBP) on which the TAIslim product is standardized.”

FreeLife is the first company to perfect a difficult and demanding proprietary process and create the most highly standardized form of the goji berry available in the world today. According to FreeLife’s Dr. Amagase, “TAIslim is the only product on the market that combines standardized goji LBP with a proprietary blend of synergistic natural ingredients, and we believe that our research demonstrates great promise for those seeking safe, effective and sustainable weight control. We are honored to have the opportunity to share our significant study results with the best and brightest experts and scientists in obesity research.”

The TAIslim formula is a result of FreeLife’s continuing commitment to cutting edge science and human clinical research. With three patents pending, no other weight loss product can approach TAIslim’s exclusive formula, scientific innovation, or clinically demonstrated efficacy.

About Norman R. Farnsworth, Ph.D.
Dr. Norman Farnsworth has been a pioneer in the development of collaborative research efforts in Pharmacognosy throughout his career. His original research publications number over 500 and have established him as a botanicals expert in both the national and international communities. He has been a member of the World Health Organization Expert Advisory Panel on Traditional Medicine since 1979, and also serves as the Director of the UIC/NIH (National Institutes of Health) Center for Botanical Dietary Supplements Research. Dr. Farnsworth serves as a Research Professor of Pharmacognosy, Distinguished University Professor and Director of the Program for Collaborative Research in the Pharmaceutical Sciences at the College of Pharmacy at the University of Illinois at Chicago (UIC).

About Marie-Pierre St-Onge, Ph.D.
Dr. St-Onge is Assistant Professor at St. Luke's/Roosevelt Hospital, and New York Obesity Research Center, Columbia University. Dr. St-Onge is an expert in obesity research and her main research interests include the study of functional foods for body weight control and cardiovascular disease prevention. She examines the effects of various whole foods or food components on energy balance, thermogenesis and appetite/food intake, as well as on metabolic risk factors, such as lipids, insulin, and glucose. She uses indirect calorimetry to assess energy expenditure and magnetic resonance imaging, dual energy X-ray absorptiometry, and computed tomography to examine the ultimate effects of various dietary interventions on body composition. Dr. St-Onge is also interested in the effects of foods on brain responses to food stimuli, using functional magnetic resonance imaging. Dr. St-Onge has won numerous awards and has publications with co-authored several book chapters.

About Haru Amagase, Ph.D.
With a rich history in the nutraceutical industry, Dr. Haru Amagase has more than 27 years of experience in Research and Development, has published more than 35 scientific papers, and holds 13 patents.

About FreeLife International
Founded in 1995, FreeLife International is a financially solid, Inc. 500 Direct Sales company based in Phoenix, Arizona. Operating in 26 countries, FreeLife’s leading products are GoChi®, Himalayan Goji® Juice, TAIslim™, and the newly introduced jiaogulan tonic, Jule of the Orient™. FreeLife’s mission is “to serve each other by promoting good health, well-being and the opportunity for an abundant life.” This statement is used to guide company decisions every day – starting with the Co-Founders and emanating to all employees at the corporate offices and the sales representatives in the field. For more information, visit http://hw.FreeLife.com."

Click here for more information on TaiSlim

Journal of Alternative and Complementary Medicine Accepts Freelife Study!

We are pleased to announce that our recent GoChi Effect study has been accepted for publication by the Journal of Alternative and Complementary Medicine (JACM)*. The study will be published in the journal’s July/August 2008 issue.

Before a clinical study is accepted for publication by a peer-reviewed medical journal such as JACM, it must first pass the scrutiny of a panel of independent experts, who review it on a blind basis (i.e., without knowing the author’s identity). These judges will not approve a study for publication unless they have ruled that its design is sound, its methods are consistent with good clinical practice, its data and calculations are accurate, and its findings are valid.

The publication of our study in this highly-regarded journal sets a new standard in our industry for the scientific validation of a product. This clearly demonstrates FreeLife’s commitment to provide you with the most effective, evidence-based and clinically-supported product available in the juice industry, GoChi™.

Entitled: “A Randomized, Double-blind, Placebo-controlled, Clinical Study of the General Effects of a Standardized Lycium barbarum (Goji) Juice, GoChi™”, this ground-breaking study shows that GoChi can improve health and well-being in 13 key areas, through a daily serving of just 4 ounces, in as little as 14 days.

Click here to read the acceptance letter.

*JACM is a medical journal covering the latest in research, theories, and reports in areas of interest to the fields of alternative and complementary medicine. It is published by MaryAnn Liebert, Inc., publisher of well-respected journals about health and medicine such as Journal of Women’s Health, Journal of Medicinal Food, Medical Acupuncture, and Human Gene Therapy.

Here is the letter:

02-Mar-2008

Dear Dr. Amagase:

We are pleased to accept your manuscript entitled "A Randomized, Double-blind, Placebo-controlled, Clinical Study of the General Effects of a Standardized Lycium barbarum (Goji) Juice, GoChi™" for publication in Journal of Alternative and Complementary Medicine. The paper is tentatively scheduled for publication in the July/August issue. You should receive page proofs electronically in June.

The Copyright Agreement form attached to this email should be sent to the publisher as soon as possible. Manuscripts cannot be published without this form. The corresponding author is responsible for obtaining signatures of coauthors. Authors not permitted to release copyright must still return the form signed under the statement of the reason for not releasing the copyright. Please fax the Copyright Agreement form to 914-740-2101.

Thank you for your contribution. On behalf of the Editors of Journal of Alternative and Complementary Medicine, we look forward to your continued contributions to the Journal.

Sincerely,
Barbara Perrin
Journal of Alternative and Complementary Medicine Editorial Office